Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Perjec

Perjeta reduces risk of death

December 11, 2012
Sales and Marketing Cancer, Perjeta, Roche

Roche’s cancer drug Perjeta helps reduce the risk of death by 34% in patients with HER2-positive metastatic breast cancer (mBC), …

News
janssen image

Alzheimer’s drug lowers mortality

December 7, 2012
Sales and Marketing Alzheimer's, Janssen, Razadyne, Roche, lilly

A study of Janssen Pharmaceuticals’ Razadyne suggests that the Alzheimer’s drug helped patients stay alive longer and slowed their cognitive …

News
tamiflu image

Roche to release Tamiflu data

November 23, 2012
Sales and Marketing BMJ, Cochrane, Goldacre, NHS, Roche, Tamiflu

Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …

News
Avastin image

Avastin shows brain cancer benefit

November 20, 2012
Research and Development, Sales and Marketing Cancer, FDA, Merck, Roche, avastin, brain

In a Phase III trial, Roche’s Avastin has helped people with newly-diagnosed glioblastoma (GBM) live longer without their disease worsening. …

News
yervoy image

NICE hails ‘breakthrough’ skin cancer treatments

November 2, 2012
Sales and Marketing BMS, NICE, Roche, Yervoy, Zelboraf

Two new skin cancer drugs have been recommended by NICE, which hailed the drugs as ‘breakthrough treatments’. Bristol-Myers Squibb’s Yervoy …

News
Roche image

Roche sees Q3 sales rise

October 16, 2012
Sales and Marketing Roche, financials

Roche’s sales for January to September this year were up 4% on the same nine-month period in 2011, with oncology …

News
lilly corporate hq image

New drugs for Alzheimer’s trial

October 15, 2012
Research and Development, Sales and Marketing Alzheimer's, Roche, lilly

Roche and Eli Lilly are providing drugs free of charge to US investigators conducting a worldwide trial of Alzheimer’s disease …

News
Avastin image

Scotland ‘no’ to Avastin

October 9, 2012
Sales and Marketing NICE, Roche, Scotland, avastin

Roche has slammed the Scottish Medicines Consortium (SMC)’s decision not to recommend Avastin for women with advanced ovarian cancer in …

News
Lucentis image

NICE does Lucentis U-turn

October 5, 2012
Sales and Marketing Lucentis, NICE, Novartis, Roche, avastin

NICE has done a U-turn over its previous verdict on Novartis’ Lucentis, now recommending the drug in draft guidance to …

News
Roche and GSK image

Is it really safety first?

October 2, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Les Rose, Roche

The idea of ensuring that drugs are adequately safe is not very old. Legislation that covers drug safety to the …

Feature
yervoy image

BMS highlights Yervoy survival data

October 1, 2012
Research and Development, Sales and Marketing BMS, Roche, Yervoy, Zelboraf

Bristol-Myers Squibb’s melanoma drug Yervoy helps patients survive for longer than if they are receiving standard chemotherapy alone, according to …

News

FDA approves Bayer’s Stivarga

October 1, 2012
Research and Development, Sales and Marketing Bayer, FDA, KRAS, Roche, Stivarga, avastin

The FDA has approved Bayer HealthCare’s oncology pill Stivarga to treat patients with metastatic colorectal cancer (mCRC) whose disease has …

News
Roche image

Roche unveils New York research base

September 26, 2012
Research and Development New York, Nutley, Roche, translational research

Roche is to locate a new translational clinical research centre in central New York, as part of a shift towards …

News

Boehringer submits new lung cancer drug

September 20, 2012
Research and Development, Sales and Marketing Boehringer, NSCLC, Roche, Tarceva, afatinib

Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …

News
Roche image

Roche winning on Perjeta supply, but running short of Boniva

August 20, 2012
Manufacturing and Production, Sales and Marketing Boniva, Perjeta, Roche, breast cancer

Roche is getting production for its new breast cancer drug Perjeta back on track after some initial teething troubles, but …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025